XML 33 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Income Taxes
12 Months Ended
Mar. 31, 2023
Income Tax Disclosure [Abstract]  
Income Taxes INCOME TAXES
The components of our income before provision for income taxes for the fiscal years ended March 31, 2023, 2022 and 2021 are as follows (in millions):
 Year Ended March 31,
 202320222021
Domestic$315 $204 $299 
Foreign1,011 877 718 
Income before provision for income taxes$1,326 $1,081 $1,017 
Provision for income taxes for the fiscal years ended March 31, 2023, 2022 and 2021 consisted of (in millions):
 CurrentDeferredTotal
Year Ended March 31, 2023
Federal$570 $(339)$231 
State92 (76)16 
Foreign75 202 277 
$737 $(213)$524 
Year Ended March 31, 2022
Federal$203 $(190)$13 
State36 (26)10 
Foreign381 (112)269 
$620 $(328)$292 
Year Ended March 31, 2021
Federal$251 $(26)$225 
State24 (2)22 
Foreign47 (114)(67)
$322 $(142)$180 
The differences between the statutory tax rate and our effective tax rate, expressed as a percentage of income before provision for income taxes, for the fiscal years ended March 31, 2023, 2022 and 2021 were as follows:
 Year Ended March 31,
 202320222021
Statutory federal tax expense rate21.0 %21.0 %21.0 %
State taxes, net of federal benefit1.1 %1.9 %1.7 %
Differences between statutory rate and foreign effective tax rate7.6 %6.8 %7.0 %
Excess tax benefit from equity compensation(0.3)%(1.2)%(2.7)%
Research and development credits(3.0)%(2.8)%(2.4)%
Swiss valuation allowance8.9 %2.7 %(10.1)%
Acquired IP intra-entity sales
— %(5.9)%— %
Non-deductible stock-based compensation3.2 %3.8 %3.3 %
Other1.0 %0.7 %(0.1)%
Effective tax rate39.5 %27.0 %17.7 %
During the fiscal year ended March 31, 2023, we recognized a $118 million tax charge to increase the valuation allowance on Swiss deferred tax assets, primarily as a result of an increase in Swiss interest rates.

During the fiscal year ended March 31, 2022, we completed intra-entity sales of intellectual property rights related to acquisitions to our U.S. and Swiss intellectual property owners (the “Acquired IP intra-entity sales”). The transactions resulted in overall taxable gains. Under U.S. GAAP, any profit resulting from the Acquired IP intra-entity sales was eliminated upon
consolidation. However, the transactions resulted in a step-up of the U.S. and Swiss tax-deductible basis in the transferred intellectual property rights and, accordingly, created a temporary difference between the book basis and the tax basis of such intellectual property rights. As a result, we recognized a $64 million net tax benefit for the current and deferred tax impacts of the sales.
In addition, during the fiscal year ended March 31, 2022, we recognized a $29 million tax charge to increase the valuation allowance on Swiss deferred tax assets that are not more likely than not to be realized.
Our effective tax rate and resulting provision for income taxes for the fiscal year ended March 31, 2021 included a $141 million tax benefit for changes in uncertain tax positions and the valuation allowance related to our Swiss deferred tax assets.
Our foreign subsidiaries are generally subject to U.S. tax, and to the extent earnings from these subsidiaries can be repatriated without a material tax cost, such earnings will not be indefinitely reinvested. As of March 31, 2023, approximately $925 million of our cash and cash equivalents were domiciled in foreign tax jurisdictions. All of our foreign cash is available for repatriation without a material tax cost.
The components of net deferred tax assets, as of March 31, 2023 and 2022 consisted of (in millions):
 As of March 31,
 20232022
Deferred tax assets:
Accruals, reserves and other expenses$197 $185 
Tax credit carryforwards218 198 
Research and development capitalization461 66 
Stock-based compensation39 43 
Net operating loss and capital loss carryforwards371 349 
Swiss intra-entity tax asset1,665 1,782 
Total2,951 2,623 
Valuation allowance(446)(296)
Deferred tax assets, net of valuation allowance2,505 2,327 
Deferred tax liabilities:
Amortization and depreciation(41)(79)
Other(3)(7)
Total(44)(86)
Deferred tax assets, net of valuation allowance and deferred tax liabilities$2,461 $2,241 
As of March 31, 2023, we have net operating loss carry forwards of approximately $2.6 billion of which approximately $213 million is attributable to various acquired companies. The net operating loss carry forwards include $2.3 billion related to Switzerland, $99 million related to U.S. federal, and $133 million related to California. Substantially all of these carryforwards, if not fully realized, will begin to expire in fiscal year 2027. Switzerland has a seven-year carryforward period and does not permit the carry back of losses. We also have U.S. federal credit carryforwards of $12 million and California credit carryforwards of $194 million. The California tax credit carryforwards can be carried forward indefinitely.
As of March 31, 2023, we maintained a total valuation allowance of $446 million related to certain U.S. state deferred tax assets, Swiss deferred tax assets, and foreign capital loss carryovers, due to uncertainty about the future realization of these assets.
The total unrecognized tax benefits as of March 31, 2023, 2022 and 2021 were $867 million, $636 million and $584 million, respectively. A reconciliation of the beginning and ending balance of unrecognized tax benefits is summarized as follows (in millions):
Balance as of March 31, 2020$983 
Increases in unrecognized tax benefits related to prior year tax positions12 
Decreases in unrecognized tax benefits related to prior year tax positions(444)
Increases in unrecognized tax benefits related to current year tax positions55 
Decreases in unrecognized tax benefits related to settlements with taxing authorities(2)
Reductions in unrecognized tax benefits due to lapse of applicable statute of limitations(27)
Changes in unrecognized tax benefits due to foreign currency translation
Balance as of March 31, 2021584 
Increases in unrecognized tax benefits related to prior year tax positions
Decreases in unrecognized tax benefits related to prior year tax positions(21)
Increases in unrecognized tax benefits related to current year tax positions139 
Decreases in unrecognized tax benefits related to settlements with taxing authorities(50)
Reductions in unrecognized tax benefits due to lapse of applicable statute of limitations(18)
Changes in unrecognized tax benefits due to foreign currency translation(3)
Balance as of March 31, 2022636 
Increases in unrecognized tax benefits related to current year tax positions245 
Decreases in unrecognized tax benefits related to settlements with taxing authorities(2)
Reductions in unrecognized tax benefits due to lapse of applicable statute of limitations(6)
Changes in unrecognized tax benefits due to foreign currency translation(6)
Balance as of March 31, 2023$867 
As of March 31, 2023, approximately $395 million of the unrecognized tax benefits would affect our effective tax rate, a portion of which would be impacted by a valuation allowance.
Interest and penalties related to estimated obligations for tax positions taken in our tax returns are recognized in income tax expense in our Consolidated Statements of Operations. The combined amount of accrued interest and penalties related to tax positions taken on our tax returns and included in non-current other liabilities was approximately $54 million as of March 31, 2023 and $36 million as of March 31, 2022.
We file income tax returns in the United States, including various state and local jurisdictions. As of March 31, 2023, our subsidiaries file tax returns in various foreign jurisdictions, including Switzerland, Canada, Sweden, Italy, France, Germany, and the United Kingdom. We remain subject to income tax examination by the IRS for fiscal years after 2017. In addition, as of the period ended March 31, 2023, we remain subject to income tax examination for several other jurisdictions including in Switzerland for fiscal years after 2013, Canada for fiscal years after 2015, Sweden for fiscal years after 2017, Italy for fiscal years after 2019, France for fiscal years after 2019, Germany for fiscal years after 2016, and the United Kingdom for fiscal years after 2021.
We are also currently under income tax examination in the United States for fiscal years 2018 through 2020 and Germany for fiscal years 2017 through 2019.
The timing and potential resolution of income tax examinations is highly uncertain. While we continue to measure our uncertain tax positions, the amounts ultimately paid, if any, upon resolution of the issues raised by the taxing authorities may differ materially from the amounts accrued.
In fiscal year 2021, the Supreme Court of the United States denied Altera’s appeal of the decision of the Ninth Circuit Court of Appeals in Altera Corp. v. Commissioner (“the Altera Opinion”), resulting in a partial decrease of our unrecognized tax benefits. A complete resolution and settlement of the matters underlying the Altera Opinion is reasonably possible within the next 12 months, which would result in an additional reduction of our gross unrecognized tax benefits. However, it is uncertain whether a complete resolution and settlement of such matters would also result in resolution of all related and unrelated U.S. positions for all applicable years. Therefore, it is not possible to provide a range of potential outcomes associated with a reversal of our gross unrecognized tax benefits for Altera-related uncertain tax positions.
It is also reasonably possible that an additional immaterial reduction of unrecognized tax benefits may occur within the next 12 months, unrelated to the Altera Opinion, a portion of which would impact our effective tax rate. The actual amount could vary significantly depending on the ultimate timing and nature of any settlements and tax interpretations.